Clinical Trial Update: Comparative Study of Techniques in Melanocyte-Keratinocyte Transplantation for the Treatment of Vitiligo [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 comparative study of melanocyte-keratinocyte transplantation techniques for treating vitiligo was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Snippet

Sponsor: Henry Ford Health System | Conditions: Vitiligo | Phase 2, Phase 3 | Status: WITHDRAWN